
Clues Intelligence LTD


London R&D hub of the US-listed AI drug discovery company, which uses machine learning and phenomics to decode biology and accelerate therapeutic development.
2 of 10 valuation pillars on file for Recursion Pharmaceuticals (London R&D).
Run the same 10-pillar coverage rubric on your company.
Run analysis on this companyLondon team focuses on AI for asset management. Barclays adopted Abacus's AI for portfolio optimization in March 2026, improving risk-adjusted returns.
Uses machine learning and NLP to reshape the delivery of primary care.
AI medical imaging company using deep learning for lung cancer detection from CT scans.
Anima provides an AI-powered care enablement platform that helps primary care clinics triage patients and automate clinical workflows.
AI safety company building Claude — frontier AI with tool use, computer use, and agentic capabilities
London team focuses on real-time NLP for contact centers. Barclays adopted ASAPP's AI for fraud detection in March 2026, reducing false positives by 30%.
Loading comments...